The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

the-alliance.org

Founded Year

1990

About The Alliance

The Alliance is a not-for-profit, employee-owned cooperative of employers and insurance trusts. It is based in Madison, Wisconsin.

The Alliance Headquarter Location

5510 Nobel Dr. Suite 200

Madison, Wisconsin, 53711,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest The Alliance News

13:06 EDT Federal Government Facilitates Access To Prescription Digital Behavioral Therapies

Mar 23, 2022

News provided by Share this article CMS Establishes Standardized Code for Insurers To Process Claims for Payment WASHINGTON, March 23, 2022 /PRNewswire/ -- Today, Aimed Alliance, the Center for U.S. Policy and the International Health Facility Diversion Association commended the federal government for facilitating patient access to prescription digital behavioral therapies. The Centers for Medicare & Medicaid Services (CMS) will establish a new medical code, effective April 1, 2022. The new Healthcare Common Procedure Coding System (HCPCS) Level II code, A9291, is intended to help health insurers provide access to digital behavioral therapies in the home setting. Aimed Alliance, a not-for-profit health policy organization, leads a working group to advance patient access to evidence-based digital therapies. Aimed Alliance supported a third-party request for the Centers for Medicare & Medicaid Services (CMS) to issue a HCPCS Level II code to facilitate payment for FDA-cleared digital therapeutics. CMS will establish a new medical code for prescription digital behavioral therapies, effective April 1, 2022. Learn more at aimedalliance.org. The Center for U.S. Policy (CUSP) is home to the Finding the 'ME' in Treatment initiative. This initiative advances policies to provide individualized health care to people with pain, substance use disorders, mental illness, and other conditions, including individuals who are incarcerated. CUSP urged the federal Interdepartmental Substance Use Disorders Coordinating Committee to provide federal coding for FDA-cleared digital therapies to help address the drug poisoning crisis. The Food & Drug Administration (FDA) has cleared a game-based digital therapeutic to improve attention in children with attention deficit hyperactivity disorder (ADHD) . The agency has cleared mobile apps to help treat substance use disorders , to help increase retention in outpatient treatment for individuals with opioid use disorder , and for treating adults with chronic insomnia . HCPCS Level II is a standard, national medical code system Medicare and other health insurance programs use to ensure that health care payment claims are processed in an orderly and consistent manner. HCPCS Level II is used primarily to identify items, supplies, and services not included in the American Medical Association's Current Procedural Terminology (CPT) coding system when used outside a health care provider's office. "CMS believes that establishing a code at this time may facilitate options for non-Medicare payers to provide access to this therapy in the home setting," the agency stated in its February 2022 coding decision . In December 2021, Aimed Alliance, which leads a working group to advance patient access to evidence-based digital therapies, supported a third-party request for CMS to issue a HCPCS Level II code for FDA-cleared digital therapeutics. "Access to a variety of in-person and remote treatment options is essential to ensure patients can conveniently obtain the health care they need," Eifer Lyddane, Aimed Alliance Board Member, stated. "CMS's decision will facilitate payment for FDA-cleared digital behavioral therapies, expand access to individually appropriate treatment, and improve public health," Ms. Lyddane said. In December 2021, the Center for U.S. Policy (CUSP), a member of the Aimed Alliance working group, urged the federal Interdepartmental Substance Use Disorders Coordinating Committee to provide federal coding for FDA-cleared digital therapies to help address the mental health, substance use disorder, and drug poisoning crises. "We thank CMS for acting with speed to expand access to evidence-based digital therapies for behavioral health," Michael Barnes, Chairman of CUSP, said. Marsha Stanton, Ph.D., R.N., President of the International Health Facility Diversion Association, which is also a working group member, said, "We applaud the federal government for facilitating the use of digital therapies and monitoring programs. Anything that we can do to improve interactions and support trust-based relationships between patients and their clinicians is a step in the right direction." About Aimed Alliance Aimed Alliance is a not-for-profit health policy organization that works to protect and enhance the rights of health care consumers and providers. Aimed Alliance leads a multidisciplinary stakeholder group that seeks to expand patient access to evidence-based digital therapies. For more information on Aimed Alliance and its initiatives, go to aimedalliance.org  and follow @aimedalliance on Twitter. About the Center for U.S. Policy (CUSP) CUSP is a nonpartisan, 501(c)(3) not-for-profit research and education organization. CUSP's 2022 issue priorities include reducing substance use disorders and their consequences, including drug poisonings. For more information on CUSP and its initiatives, go to centerforuspolicy.org and follow @USPolicyCenter on Twitter. About the International Health Facility Diversion Association (IHFDA) IHFDA is an international network of professionals devoted to protecting patients, staff, and facilities from the harms associated with drug diversion and substance misuse by healthcare personnel. For more information on IHFDA, go to ihfda.org  and follow @ihfda_org  on Twitter. SOURCE Center for U.S. Policy ×

The Alliance Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

The Alliance Rank

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.